Application no. and date | 10781884.1 (espacenet) (Federated) (European Patent Register), 20101118 | Patent/reg. no. and date | DK/EP 2501683, 20140423 | Publication date | 20120926 | Priority no. and date | US 263137 P, 20091120, US 359914 P, 20100630 | EP pub. no. and date |
EP 2501683 20120926 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35 4056 Basel, CH | Applicant ref. no. | NGC/AP/149008 | Inventor | IWAKI, Yuki, Novartis Institutes for BioMedical Research Inc. 400 Technology Square
Cambridge, Massachusetts 02139, US, KAWANAMI, Toshio, Novartis Institutes for BioMedical Research Inc. 100 Technology Square
Cambridge, Massachusetts 0213, US, KSANDER, Gary Michael, Novartis Institutes for BioMedical Research Inc. 100 Technology Square
Cambridge, Massachusetts 02139, US, MOGI, Muneto, Novartis Institutes for BioMedical Research Inc. 100 Technology Square
Cambridge, Massachusetts 02139, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/41 (2006.01) , A61K 31/415 (2006.01) , A61K 31/42 (2006.01) , A61P 7/10 (2006.01) , C07D 231/40 (2006.01) , C07D 257/06 (2006.01) , C07D 261/14 (2006.01) | Title | Substituerede carbamoylmethylaminoeddikesyrederivater som nye NEP-inhibitorer | Int. application no. | EP2010067781 | Int. publication no. | WO2011061271 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|